Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Nu Skin Enterprises Inc is a household & personal products business based in the US. Nu Skin Enterprises shares (NUS) are listed on the NYSE and all prices are listed in US Dollars. Nu Skin Enterprises employs 5,000 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$41.27|
|52-week range||$41.25 - $62.51|
|50-day moving average||$50.70|
|200-day moving average||$54.33|
|Wall St. target price||$67.20|
|Dividend yield||$1.51 (3.62%)|
|Earnings per share (TTM)||$4.56|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-09-17)||-5.28%|
|1 month (2021-08-24)||-20.31%|
|3 months (2021-06-24)||-28.49%|
|6 months (2021-03-24)||-18.70%|
|1 year (2020-09-24)||-19.24%|
|2 years (2019-09-24)||-3.51%|
|3 years (2018-09-24)||85.46|
|5 years (2016-09-23)||63.12|
Valuing Nu Skin Enterprises stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Nu Skin Enterprises's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Nu Skin Enterprises's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 10x. In other words, Nu Skin Enterprises shares trade at around 10x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Nu Skin Enterprises's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.35. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Nu Skin Enterprises's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Nu Skin Enterprises's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $385.8 million.
The EBITDA is a measure of a Nu Skin Enterprises's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$2.8 billion|
|Operating margin TTM||10.99%|
|Gross profit TTM||$1.9 billion|
|Return on assets TTM||10.12%|
|Return on equity TTM||27.67%|
|Market capitalisation||$2.2 billion|
TTM: trailing 12 months
There are currently 2.3 million Nu Skin Enterprises shares held short by investors – that's known as Nu Skin Enterprises's "short interest". This figure is 3.8% down from 2.4 million last month.
There are a few different ways that this level of interest in shorting Nu Skin Enterprises shares can be evaluated.
Nu Skin Enterprises's "short interest ratio" (SIR) is the quantity of Nu Skin Enterprises shares currently shorted divided by the average quantity of Nu Skin Enterprises shares traded daily (recently around 342500.14619883). Nu Skin Enterprises's SIR currently stands at 6.84. In other words for every 100,000 Nu Skin Enterprises shares traded daily on the market, roughly 6840 shares are currently held short.
However Nu Skin Enterprises's short interest can also be evaluated against the total number of Nu Skin Enterprises shares, or, against the total number of tradable Nu Skin Enterprises shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Nu Skin Enterprises's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Nu Skin Enterprises shares in existence, roughly 50 shares are currently held short) or 0.0505% of the tradable shares (for every 100,000 tradable Nu Skin Enterprises shares, roughly 51 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Nu Skin Enterprises.
Find out more about how you can short Nu Skin Enterprises stock.
Dividend payout ratio: 33.37% of net profits
Recently Nu Skin Enterprises has paid out, on average, around 33.37% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.49% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Nu Skin Enterprises shareholders could enjoy a 3.49% return on their shares, in the form of dividend payments. In Nu Skin Enterprises's case, that would currently equate to about $1.51 per share.
While Nu Skin Enterprises's payout ratio might seem fairly standard, it's worth remembering that Nu Skin Enterprises may be investing much of the rest of its net profits in future growth.
Nu Skin Enterprises's most recent dividend payout was on 7 September 2021. The latest dividend was paid out to all shareholders who bought their shares by 25 August 2021 (the "ex-dividend date").
Over the last 12 months, Nu Skin Enterprises's shares have ranged in value from as little as $41.25 up to $62.5059. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Nu Skin Enterprises's is 1.1512. This would suggest that Nu Skin Enterprises's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Nu Skin Enterprises, Inc. develops and distributes personal care and wellness products worldwide. It provides skin care systems, including ageLOC Me customized skin care and ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products comprising botanical ingredients derived from renewable sources, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, and LifePak nutritional supplements, as well as other anti-aging nutritional solutions and weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands.
Everything we know about the Enfusion IPO, plus information on how to buy in.
Everything we know about the Intuity Medical IPO, plus information on how to buy in.
Everything we know about the Pyxis Oncology IPO, plus information on how to buy in.
Everything we know about the AEON Biopharma IPO, plus information on how to buy in.
Everything we know about the IHS Holding Ltd IPO, plus information on how to buy in.
Everything we know about the BT Brands IPO, plus information on how to buy in.
Everything we know about the Immix IPO, plus information on how to buy in.
Everything we know about the Keter Group SA IPO, plus information on how to buy in.
Everything we know about the Theseus Pharmaceuticals IPO, plus information on how to buy in.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq on Sep. 20, 2021
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.